IL17A and immune dysregulation-polyendocrinopathy-enteropathy-X-linked syndrome: Anti–IFN type I, anti–IL-17, and anti–IL-12 antibodies, which have been linked to susceptibility to infections, have been identified in patients with IPEX syndrome (1, 19), although without a proven clinical correlate (19, 33).